Oventus Medical Limited announced consolidated and parent earnings results for the full year ended June 30, 2018. For the period, on consolidated basis, the company reported Revenue ­ sale of goods of AUD 271,322 compared to AUD 447,994 for the same period a year ago. Loss before interest and tax was AUD 5,870,547 compared to AUD 6,510,114 for the same period a year ago. Diluted loss per share was 5.92 cents compared to 9.18 cents for the same period a year ago. Loss for the year attributable to members of the company was AUD 5,870,547 compared to AUD 6,510,114 for the same period a year ago. Net cash outflow from operating activities was AUD 4,635,049 compared to AUD 5,530,076 for the same period a year ago. Payments for property, plant and equipments was AUD 66,836 compared to AUD 249,959 for the same period a year ago. Payments for intangible assets was AUD 1,954,802 compared to AUD 2,251,874 for the same period a year ago. Net tangible assets per ordinary security was 11.18 cents compared to 11.63 cents for the same period a year ago. For the period, on parent basis, the company reported Loss after income tax was AUD 786,462 compared to AUD 760,992 for the same period a year ago.